DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Stock Information | RedChip

DiaMedica Therapeutics Inc. (NASDAQ: DMAC)


$5.3600
-0.0150 ( +0.19% ) 18.4K

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Market Data


Open


$5.3600

Previous close


$5.3750

Volume


18.4K

Market cap


$228.13M

Day range


$5.2300 - $5.5050

52 week range


$2.1400 - $6.4100

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jan 02, 2024
4 Insider transactions 1 Jan 02, 2024
4 Insider transactions 1 Jan 02, 2024

Latest News